Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,424.85 162.29 1.00%
S&P 500 1,862.31 19.33 1.05%
NASDAQ 4,086.22 52.06 1.29%
Ticker Volume Price Price Delta
STOXX 50 3,139.26 47.74 1.54%
FTSE 100 6,584.17 42.56 0.65%
DAX 9,317.82 144.11 1.57%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

/C O R R E C T I O N -- Sanford Heisler, LLP/



                /C O R R E C T I O N -- Sanford Heisler, LLP/

PR Newswire

NEWARK, N.J., Nov. 5, 2012

In the news release, Six New Plaintiffs Join Sanford Heisler's $100m Gender
Discrimination Class Action Against Forest Laboratories & Forest
Pharmaceuticals, issued Nov. 5, 2012 by Sanford Heisler, LLP over PR Newswire,
we are advised by the law firm that the dateline should read "NEW YORK" rather
than "NEWARK, N.J." as originally issued inadvertently. The complete,
corrected release follows:

  Six New Plaintiffs Join Sanford Heisler's $100m Gender Discrimination Class
  Action Against Forest Laboratories & Forest Pharmaceuticals

    Ten Former and Current Mothers and Pregnant Women Cite Egregious
    Conditions

NEW YORK, Nov. 5, 2012 /PRNewswire/ -- Sanford Heisler, LLP, today added six
additional female plaintiffs to the $100 million gender discrimination
employment class action complaint the firm initially filed in July against New
York-based Forest Laboratories, Inc., and Forest Pharmaceuticals, Inc.

The amended complaint was filed in the federal court for the Southern District
of New York this morning. It increases the number of named plaintiffs to ten
and provides additional support to the assertion that Forest discriminates
against its female employees from coast to coast.

"The amended complaint reflects the unfortunate reality that the first four
named plaintiffs comprise just a fraction of the women subjected to gender
discrimination at Forest Pharmaceuticals," said David Sanford, Chairman of
Sanford Heisler LLP and lead attorney for the plaintiffs. "Information about
the full extent of the hostile work environment that pregnant women and
mothers endure companywide continues to emerge, as more and more women
employed by this pharma giant find out that much of what they are subjected to
as Forest employees is illegal. We expect this class to be quite large."

The new named plaintiffs – all of whom are current or former high-performing
Forest sales representatives – are Los Angeles residents Kimberly Clinton and
Maria Avila; York, PA, resident Erin Eckenrode; Lebanon, PA, resident Julie
Smyth; Louisville, KY, resident Andrea Harley; and Girard, IL, resident
Christy Louder. The four original plaintiffs are Pennsylvania resident Megan
Barrett and Texas residents, Lindsey Houser, Jennifer Jones and Jennifer
Seard.

All ten named plaintiffs are current or former sales representatives of
Forest. "This case is very similar in many ways to the Novartis gender
discrimination case we tried in the Southern District of New York in 2010
where, on behalf of the female sales reps, we won a $253 million jury
verdict," said Mr. Sanford.

The original and amended complaints assert Forest's female sales
representatives have been and continue to be paid less than similarly situated
male employees, despite the women's exemplary work performance. As a result of
their gender, all ten of the named plaintiffs were denied bonuses, promotions,
stock options and other employment incentives to which they were entitled.

Today's complaint also adds additional documentation about Forest's pervasive
pattern of discrimination and harassment of pregnant sales representatives and
female sales representatives responsible for the care of their young or ill
children.  It also offers strong support for the ten plaintiffs' common
assertions that Forest ignores, disregards, minimizes, covers up or mishandles
evidence of gender discrimination nationwide.

The experiences of the women added by this amended complaint echo those of the
original plaintiffs: When females reported the discrimination and harassment
to which they were subjected to their superiors or to the company's human
resource department, each of them was retaliated against and several lost
their jobs. Furthermore, no disciplinary action was taken against the males
who discriminated against and harassed them.

"We do not know whether Forest does not have or does not choose to follow the
gender neutral policies, practices and procedures that are required by federal
and state laws," said Katherine Leong, a member of the litigation team at
Sanford Heisler. "We also do not know why – when Forest is provided repeatedly
with information that pregnant women and mothers are among those most severely
harassed and discriminated against -- that this giant company consistently
ignores these reports and punishes the women who make them. What we do know is
that this gender harassment and discrimination have already persisted too long
and must be brought to an end."

Forest Laboratories' (NYSE: FRX) is a global company that develops and markets
prescription and non-prescription pharmaceutical products across the United
States. On October 16, 2012, the company projected a 2013 income of $3.2
billion.

Today's amended filing seeks class certification as the most efficient,
economical means of addressing the questions of law common to the plaintiffs'
claims of a systematic pattern and practice of gender discrimination by Forest
against its female employees. The complaint also seeks a declaratory judgment
that Forest has engaged in systemic gender discrimination; a permanent
injunction against continuing discrimination; and injunctive relief that
includes a restructuring of many of Forest's personnel policies and procedures
so that females can compete fairly in the future under the conditions of
employment traditionally enjoyed by the company's male employees. 

In addition, equitable relief in the form of a restructuring at Forest so that
female employees advance into the higher and better-paying jobs they would
have held in the absence of Forest's pervasive gender discrimination is
requested. Back pay, front pay and other equitable remedies that will redress
the past discrimination, as well as compensatory damages, punitive damages and
court and legal fees are also requested, as is a jury trial.

About Sanford Heisler, LLP

Sanford Heisler is a law firm with offices in Washington, D.C., New York, and
San Francisco that specializes in employment discrimination, wage and hour,
qui tam and consumer actions and complex corporate class action litigation and
has represented thousands of individuals in major class action cases in the
United States. The firm also represents individual clients in employment,
employment discrimination, sexual harassment, whistleblower, public
accommodations, commercial, medical malpractice, and personal injury matters.
In May 2010, the firm won the largest jury award in the U.S. in a gender
discrimination employment class action when a jury returned a verdict of $253
million in compensatory and punitive damages against Novartis Pharmaceuticals
Corporation.  In 2012, the firm won court approval to settle a wage and hour
case on behalf of sales reps employed by Novartis Pharmaceuticals for $99
million.  For more information, contact Sanford Heisler at (202) 742-7777.

For more information, contact Jamie Moss, newsPRos, 201-493-1027,
Jamie@newspros.com

 

SOURCE Sanford Heisler, LLP
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement